Company Overview of Kémia, Inc.
Kémia, Inc. operates as a pharmaceutical company. The company discovers and develops small molecule therapeutics. It offers allosteric kinase inhibitors for the treatment of inflammatory diseases, such as rheumatoid arthritis, as well as for cardiovascular and metabolic conditions; and modulators of G protein-coupled receptors. The company specializes in the fields of medicinal and analytical chemistry, biology, pharmacology, pharmacokinetics, pharmacodynamics, and clinical development. Kémia, Inc. was incorporated in 2001 and is based in San Diego, California.
5871 Oberlin Drive
San Diego, CA 92121
Founded in 2001
Key Executives for Kémia, Inc.
Kémia, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Biotherapies, Inc.||United States|
|Matrivax Research & Development Corp.||United States|
|Genotec Nutritionals, Inc.||United States|
|Johnson & Johnson International, Inc.||United States|
|Health Plus International, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Kémia, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.